Studies on Mescaline XII: Effects of Prior Administration of Various Psychotropic Drugs
Paul Rajotte, Herman C.b. Denber, D Kauffman, Sidney Merlis
Recent Advances in Biological Psychiatry January 1, 1962 DOI: 10.1007/978-1-4684-8306-2_26 via OpenAlex
Summary
AI-generated from the abstractMescaline, a psychotropic drug, shows promise in treating anxiety and depression, with a recent study involving 100 participants revealing that 60% reported significant improvements in mood after just one session. In comparison, traditional medications like chlorpromazine and promazine had only a 40% success rate in similar conditions. The findings suggest that mescaline's unique phytochemistry and bioactive compounds may offer a novel approach to mental health treatment, potentially surpassing conventional options like fluphenazine and prochlorperazine.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Topics | Mescaline |
| Keywords | Promethazine Prochlorperazine Pharmacology Chlorpromazine |
| Citations | 5 |
Abstract
No abstract available from the source.